COVID-19 Positivity Lower for Some With Psychiatric Disorders
TUESDAY, Nov. 23, 2021 (HealthDay News) — Patients with psychiatric disorders, including...
Read More
Block Words
American College of Rheumatology, Nov. 3-9
The annual meeting of the American College of Rheumatology was held virtually this year from Nov....
Read More
American Academy of Ophthalmology, Nov. 12-15
The annual meeting of the American Academy of Ophthalmology was held from Nov. 12 to 15 in New...
Read More
Sacubitril-Valsartan Does Not Cut Risk for Death, Heart Failure After MI
MONDAY, Nov. 22, 2021 (HealthDay News) — For patients with myocardial infarction,...
Read More
Pfizer Says Its COVID-19 Vaccine Provides Full Protection to Adolescents
MONDAY, Nov. 22, 2021 (HealthDay News) — Pfizer Inc. said Monday that its COVID-19 vaccine...
Read More
Annual Mammography Not Cost-Effective Beyond 75 Years
MONDAY, Nov. 22, 2021 (HealthDay News) — Annual mammography beyond 75 years is not...
Read More
30 Percent of Hospital-Based Health Care Personnel Unvaccinated
MONDAY, Nov. 22, 2021 (HealthDay News) — A considerable proportion of hospital-based health...
Read More
Risk for Stillbirth Elevated for Deliveries With COVID-19
MONDAY, Nov. 22, 2021 (HealthDay News) — The risk for stillbirth is elevated in deliveries...
Read MoreOutcomes and their State-Level Variation in Patients Undergoing Surgery with Perioperative SARS-CoV-2 Infection in the USA: A Prospective Multicenter Study.
To report the 30-day outcomes of patients with perioperative SARS-CoV-2 infection undergoing surgery in the USA.Uncertainty regarding the postoperative risks of patients with severe acute respiratory syndrome coronavirus 2...
Read MoreBetter outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases.
Τo report outcomes of breakthrough COVID-19 in comparison with COVID-19 in unvaccinated patients with systemic rheumatic diseases (SRDs).Patients with SRD with COVID-19 (vaccinated and unvaccinated) were included by their...
Read MoreSafety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.
The safety and immunogenicity profile of COVID-19 vaccines when administered concomitantly with seasonal influenza vaccines have not yet been reported. We therefore aimed to report the results of a substudy within a phase 3 UK...
Read MoreWelcomeness for people with substance use disorders to general practice: a qualitative study.
Good primary care for people with substance use disorders (SUDs) is crucial given the high prevalence of SUDs and overdose deaths.To explore general practice care for people with a history of SUDs from the perspectives of women...
Read MoreBrain injury and inflammation genes common to a number of neurological diseases and the genes involved in the genesis of GABAnergic neurons are altered in monoamine oxidase B knockout mice.
Monoamine oxidase B (MAO B) oxidizes trace amine phenylethylamine (PEA), and neurotransmitters serotonin and dopamine in the brain. We reported previously that PEA levels increased significantly in all brain regions, but...
Read MoreAn Evaluation of Knowledge, Awareness, Attitudes, and Behaviors Regarding COVID-19 Among Parents of Pediatric Dental Patients.
Children infected with COVID-19 have a critical part in community-based viral transmission. This study aimed to evaluate knowledge, awareness, attitudes, and behaviors of parents of pediatric dental patients on COVID-19 and to...
Read MoreValidating the UK prospective diabetes study outcome model 2 using data of 94,946 Israeli patients with type 2 diabetes.
To externally validate the United Kingdom Prospective Diabetes Study (UKPDS) Outcome Model 2 (OM2) in contemporary Israeli patient populations.De-identified patient data on demographics, time-varying risk factors, and clinical...
Read MoreXuesaitong oral preparation as adjuvant therapy for treating acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trials.
Cerebral infarction is the second leading cause of death and the third most common cause of disability. The use of anti-platelet aggregation drugs is prone to bleeding, liver and kidney damage, gastrointestinal reactions, and is...
Read MoreCauses of Death in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Alcoholic Liver Disease and Chronic Viral Hepatitis B and C.
Cause of mortality in patients with chronic liver diseases (CLDs) may differ based on underlying etiology of liver disease. Our aim was to assess different causes of death in patients with the most common types of CLD using a...
Read MoreThe impact of behavioural risk factors on communicable diseases: a systematic review of reviews.
The coronavirus (COVID-19) pandemic has highlighted that individuals with behavioural risk factors commonly associated with non-communicable diseases (NCDs), such as smoking, harmful alcohol use, obesity, and physical...
Read MoreDetection of COVID-19 by Machine Learning Using Routine Laboratory Tests.
The present study aimed to develop a clinical decision support tool to assist coronavirus disease 2019 (COVID-19) diagnoses with machine learning (ML) models using routine laboratory test results.We developed ML models using...
Read MoreCHEMOTHERAPY, HYPOTHYROIDISM AND ORAL DYSBIOSIS AS A NOVEL RISK FACTOR OF CARDIOVASCULAR PATHOLOGY DEVELOPMENT.
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the population, as well as the economic burden of the health care system. Currently, CVDs account for more than 17.6 million deaths a year and...
Read More